| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00061 | 1 |